blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3215177

EP3215177 - PHORBOL ESTER COMPOSITIONS AND METHODS FOR TREATING OR REDUCING THE DURATION OF CYTOPENIA [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.03.2023
Database last updated on 25.09.2024
FormerThe patent has been granted
Status updated on  08.04.2022
FormerGrant of patent is intended
Status updated on  02.12.2021
FormerExamination is in progress
Status updated on  14.12.2018
FormerRequest for examination was made
Status updated on  11.08.2017
FormerThe international publication has been made
Status updated on  01.11.2016
Most recent event   Tooltip06.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 09.10.2024 [2024/41]
Applicant(s)For all designated states
Biosuccess Biotech Co. Ltd.
2570 North First Street Suite 200
San Jose CA 95131 / US
[2017/42]
Former [2017/37]For all designated states
Hygeia Technology Inc.
3033-8700 Mckim Way
Richmond, British Columbia V6X 4A5 / CA
Inventor(s)01 / HAN, Zheng Tao
Eugene, Oregon 97402 / US
 [2022/16]
Former [2017/37]01 / HAN, Zheng Tao
1080 Patterson St.
Apt. 903
Eugene, Oregon 97401 / US
Representative(s)Harris, Oliver John Richard
Novagraaf UK
Centrum
Norwich Research Park
Colney Lane
Norwich NR4 7UG / GB
[2017/37]
Application number, filing date15791889.703.11.2015
[2017/37]
WO2015US58732
Priority number, dateUS201462074133P03.11.2014         Original published format: US 201462074133 P
[2017/37]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016073416
Date:12.05.2016
Language:EN
[2016/19]
Type: A1 Application with search report 
No.:EP3215177
Date:13.09.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 12.05.2016 takes the place of the publication of the European patent application.
[2017/37]
Type: B1 Patent specification 
No.:EP3215177
Date:11.05.2022
Language:EN
[2022/19]
Search report(s)International search report - published on:EP12.05.2016
ClassificationIPC:A61K38/19, A61P7/00, A61P7/06, A61K31/235, A61K31/22, A61K38/18, A61K31/23, A61P7/04, A61P35/02, A61P43/00
[2021/50]
CPC:
A61K31/23 (EP,IL,US); A61K31/22 (EP,CN,IL,KR,RU,US); A61K38/193 (EP,CN,IL,KR,RU,US);
A61K31/235 (EP,IL,KR,US); A61K38/1816 (EP,CN,IL,KR,US); A61P35/02 (EP,IL);
A61P43/00 (EP,IL); A61P7/00 (EP,IL); A61P7/04 (EP,IL);
A61P7/06 (EP,IL,RU); A61K2300/00 (IL,KR) (-)
C-Set:
A61K31/22, A61K2300/00 (EP,CN,US);
A61K31/235, A61K2300/00 (US,EP);
A61K38/1816, A61K2300/00 (US,CN,EP);
A61K38/193, A61K2300/00 (US,CN,EP)
Former IPC [2017/37]A61K38/19, A61K31/22, A61K31/235, A61P7/06, A61P7/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/37]
Extension statesBA31.05.2017
ME31.05.2017
Validation statesMA31.05.2017
MD05.06.2017
TitleGerman:PHORBOL-ESTER ZUSAMMENSETZUNGEN UND METHODEN ZUR BEHANDLUNG ODER VERKÜRZUNG DER DAUER DER ZYTOPENIE[2021/50]
English:PHORBOL ESTER COMPOSITIONS AND METHODS FOR TREATING OR REDUCING THE DURATION OF CYTOPENIA[2017/37]
French:COMPOSITIONS COMPRENANT UN ESTER DE PHORBOL ET METHODES POUR LE TRAITEMENT OU REDUCTION DE LA DUREE DE LA CYTOPENIE[2021/50]
Former [2017/37]PHORBOLESTERZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG ODER VERRRINGERUNG DER DAUER VON ZYTOPENIE
Former [2017/37]COMPOSITIONS D'ESTER DE PHORBOL ET PROCÉDÉS POUR TRAITER OU RÉDUIRE LA DURÉE D'UNE CYTOPÉNIE
Entry into regional phase31.05.2017National basic fee paid 
31.05.2017Designation fee(s) paid 
31.05.2017Examination fee paid 
Examination procedure22.08.2016Request for preliminary examination filed
International Preliminary Examining Authority: EP
31.05.2017Examination requested  [2017/37]
31.05.2017Date on which the examining division has become responsible
18.12.2017Amendment by applicant (claims and/or description)
18.12.2018Despatch of a communication from the examining division (Time limit: M06)
24.06.2019Reply to a communication from the examining division
07.01.2020Despatch of a communication from the examining division (Time limit: M06)
07.07.2020Reply to a communication from the examining division
03.12.2021Communication of intention to grant the patent
31.03.2022Fee for grant paid
31.03.2022Fee for publishing/printing paid
31.03.2022Receipt of the translation of the claim(s)
Opposition(s)14.02.2023No opposition filed within time limit [2023/16]
Fees paidRenewal fee
10.01.2018Renewal fee patent year 03
28.11.2018Renewal fee patent year 04
23.10.2019Renewal fee patent year 05
13.11.2020Renewal fee patent year 06
21.10.2021Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
30.11.201703   M06   Fee paid on   10.01.2018
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU03.11.2015
AL11.05.2022
AT11.05.2022
CY11.05.2022
CZ11.05.2022
DK11.05.2022
EE11.05.2022
ES11.05.2022
FI11.05.2022
HR11.05.2022
IT11.05.2022
LT11.05.2022
LV11.05.2022
MC11.05.2022
MK11.05.2022
MT11.05.2022
NL11.05.2022
PL11.05.2022
RO11.05.2022
RS11.05.2022
SE11.05.2022
SI11.05.2022
SK11.05.2022
SM11.05.2022
BG11.08.2022
NO11.08.2022
GR12.08.2022
IS11.09.2022
PT12.09.2022
IE03.11.2022
LU03.11.2022
BE30.11.2022
[2024/41]
Former [2024/27]HU03.11.2015
AL11.05.2022
AT11.05.2022
CY11.05.2022
CZ11.05.2022
DK11.05.2022
EE11.05.2022
ES11.05.2022
FI11.05.2022
HR11.05.2022
IT11.05.2022
LT11.05.2022
LV11.05.2022
MC11.05.2022
MK11.05.2022
NL11.05.2022
PL11.05.2022
RO11.05.2022
RS11.05.2022
SE11.05.2022
SI11.05.2022
SK11.05.2022
SM11.05.2022
BG11.08.2022
NO11.08.2022
GR12.08.2022
IS11.09.2022
PT12.09.2022
IE03.11.2022
LU03.11.2022
BE30.11.2022
Former [2024/21]HU03.11.2015
AL11.05.2022
AT11.05.2022
CY11.05.2022
CZ11.05.2022
DK11.05.2022
EE11.05.2022
ES11.05.2022
FI11.05.2022
HR11.05.2022
IT11.05.2022
LT11.05.2022
LV11.05.2022
MC11.05.2022
NL11.05.2022
PL11.05.2022
RO11.05.2022
RS11.05.2022
SE11.05.2022
SI11.05.2022
SK11.05.2022
SM11.05.2022
BG11.08.2022
NO11.08.2022
GR12.08.2022
IS11.09.2022
PT12.09.2022
IE03.11.2022
LU03.11.2022
BE30.11.2022
Former [2024/18]HU03.11.2015
AL11.05.2022
AT11.05.2022
CZ11.05.2022
DK11.05.2022
EE11.05.2022
ES11.05.2022
FI11.05.2022
HR11.05.2022
IT11.05.2022
LT11.05.2022
LV11.05.2022
MC11.05.2022
NL11.05.2022
PL11.05.2022
RO11.05.2022
RS11.05.2022
SE11.05.2022
SI11.05.2022
SK11.05.2022
SM11.05.2022
BG11.08.2022
NO11.08.2022
GR12.08.2022
IS11.09.2022
PT12.09.2022
IE03.11.2022
LU03.11.2022
BE30.11.2022
Former [2024/11]AL11.05.2022
AT11.05.2022
CZ11.05.2022
DK11.05.2022
EE11.05.2022
ES11.05.2022
FI11.05.2022
HR11.05.2022
IT11.05.2022
LT11.05.2022
LV11.05.2022
MC11.05.2022
NL11.05.2022
PL11.05.2022
RO11.05.2022
RS11.05.2022
SE11.05.2022
SI11.05.2022
SK11.05.2022
SM11.05.2022
BG11.08.2022
NO11.08.2022
GR12.08.2022
IS11.09.2022
PT12.09.2022
IE03.11.2022
LU03.11.2022
BE30.11.2022
Former [2023/49]AL11.05.2022
AT11.05.2022
CZ11.05.2022
DK11.05.2022
EE11.05.2022
ES11.05.2022
FI11.05.2022
HR11.05.2022
LT11.05.2022
LV11.05.2022
MC11.05.2022
NL11.05.2022
PL11.05.2022
RO11.05.2022
RS11.05.2022
SE11.05.2022
SI11.05.2022
SK11.05.2022
SM11.05.2022
BG11.08.2022
NO11.08.2022
GR12.08.2022
IS11.09.2022
PT12.09.2022
IE03.11.2022
LU03.11.2022
BE30.11.2022
Former [2023/48]AL11.05.2022
AT11.05.2022
CZ11.05.2022
DK11.05.2022
EE11.05.2022
ES11.05.2022
FI11.05.2022
HR11.05.2022
LT11.05.2022
LV11.05.2022
MC11.05.2022
NL11.05.2022
PL11.05.2022
RO11.05.2022
RS11.05.2022
SE11.05.2022
SI11.05.2022
SK11.05.2022
SM11.05.2022
BG11.08.2022
NO11.08.2022
GR12.08.2022
IS11.09.2022
PT12.09.2022
IE03.11.2022
LU03.11.2022
Former [2023/37]AL11.05.2022
AT11.05.2022
CZ11.05.2022
DK11.05.2022
EE11.05.2022
ES11.05.2022
FI11.05.2022
HR11.05.2022
LT11.05.2022
LV11.05.2022
MC11.05.2022
NL11.05.2022
PL11.05.2022
RO11.05.2022
RS11.05.2022
SE11.05.2022
SI11.05.2022
SK11.05.2022
SM11.05.2022
BG11.08.2022
NO11.08.2022
GR12.08.2022
IS11.09.2022
PT12.09.2022
LU03.11.2022
Former [2023/30]AL11.05.2022
AT11.05.2022
CZ11.05.2022
DK11.05.2022
EE11.05.2022
ES11.05.2022
FI11.05.2022
HR11.05.2022
LT11.05.2022
LV11.05.2022
MC11.05.2022
NL11.05.2022
PL11.05.2022
RO11.05.2022
RS11.05.2022
SE11.05.2022
SI11.05.2022
SK11.05.2022
SM11.05.2022
BG11.08.2022
NO11.08.2022
GR12.08.2022
IS11.09.2022
PT12.09.2022
Former [2023/25]AL11.05.2022
AT11.05.2022
CZ11.05.2022
DK11.05.2022
EE11.05.2022
ES11.05.2022
FI11.05.2022
HR11.05.2022
LT11.05.2022
LV11.05.2022
NL11.05.2022
PL11.05.2022
RO11.05.2022
RS11.05.2022
SE11.05.2022
SI11.05.2022
SK11.05.2022
SM11.05.2022
BG11.08.2022
NO11.08.2022
GR12.08.2022
IS11.09.2022
PT12.09.2022
Former [2023/17]AL11.05.2022
AT11.05.2022
CZ11.05.2022
DK11.05.2022
EE11.05.2022
ES11.05.2022
FI11.05.2022
HR11.05.2022
LT11.05.2022
LV11.05.2022
NL11.05.2022
PL11.05.2022
RO11.05.2022
RS11.05.2022
SE11.05.2022
SK11.05.2022
SM11.05.2022
BG11.08.2022
NO11.08.2022
GR12.08.2022
IS11.09.2022
PT12.09.2022
Former [2023/09]AT11.05.2022
CZ11.05.2022
DK11.05.2022
EE11.05.2022
ES11.05.2022
FI11.05.2022
HR11.05.2022
LT11.05.2022
LV11.05.2022
NL11.05.2022
PL11.05.2022
RO11.05.2022
RS11.05.2022
SE11.05.2022
SK11.05.2022
SM11.05.2022
BG11.08.2022
NO11.08.2022
GR12.08.2022
IS11.09.2022
PT12.09.2022
Former [2023/07]AT11.05.2022
DK11.05.2022
ES11.05.2022
FI11.05.2022
HR11.05.2022
LT11.05.2022
LV11.05.2022
NL11.05.2022
PL11.05.2022
RS11.05.2022
SE11.05.2022
BG11.08.2022
NO11.08.2022
GR12.08.2022
IS11.09.2022
PT12.09.2022
Former [2022/51]AT11.05.2022
ES11.05.2022
FI11.05.2022
HR11.05.2022
LT11.05.2022
LV11.05.2022
NL11.05.2022
PL11.05.2022
RS11.05.2022
SE11.05.2022
BG11.08.2022
NO11.08.2022
GR12.08.2022
IS11.09.2022
PT12.09.2022
Former [2022/50]AT11.05.2022
ES11.05.2022
FI11.05.2022
HR11.05.2022
LT11.05.2022
LV11.05.2022
NL11.05.2022
PL11.05.2022
RS11.05.2022
SE11.05.2022
BG11.08.2022
NO11.08.2022
GR12.08.2022
PT12.09.2022
Former [2022/49]AT11.05.2022
ES11.05.2022
FI11.05.2022
HR11.05.2022
LT11.05.2022
LV11.05.2022
NL11.05.2022
SE11.05.2022
BG11.08.2022
NO11.08.2022
GR12.08.2022
PT12.09.2022
Former [2022/48]AT11.05.2022
ES11.05.2022
FI11.05.2022
LT11.05.2022
NL11.05.2022
SE11.05.2022
NO11.08.2022
PT12.09.2022
Former [2022/47]AT11.05.2022
ES11.05.2022
FI11.05.2022
LT11.05.2022
SE11.05.2022
NO11.08.2022
PT12.09.2022
Cited inInternational search[X]US2014206762  (HAN ZHENG TAO [CN], et al) [X] 18-24 * claims 101,104,105,106 ** abstract *;
 [XI]  - J L SPIVAK ET AL, "Tumor-promoting phorbol esters support the in vitro proliferation of murine pluripotent hematopoietic stem cells.", JOURNAL OF CLINICAL INVESTIGATION, US, (19890101), vol. 83, no. 1, doi:10.1172/JCI113844, ISSN 0021-9738, pages 100 - 107, XP055237296 [X] 1,2,5,7-17 * abstract * * page 100, column r, paragraph 1 - paragraph 2 * * table 8 * * page 105, column l, paragraph 1 * [I] 3,4,6

DOI:   http://dx.doi.org/10.1172/JCI113844
ExaminationWO2013110006
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.